Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 28, 2013
- Accepted for publication November 11, 2013
- Published online April 1, 2014.
Article Versions
- previous version (February 27, 2014 - 05:22).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Jack M. Webster1,
- Christine A. Morton1,
- Bruce F. Johnson1,
- Hua Yang2,
- Michael J. Rishel1,
- Brian D. Lee1,
- Qing Miao2,
- Chittari Pabba1,
- Donald T. Yapp3,4 and
- Paul Schaffer2
- 1Diagnostics and Biomedical Technologies, GE Global Research, Niskayuna, New York
- 2Nuclear Medicine Division, TRIUMF, Vancouver, British Columbia, Canada
- 3Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada; and
- 4Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada
- For correspondence or reprints contact: Jack M. Webster, GE Global Research, One Research Circle, K1-5D57, Niskayuna, NY 12309. E-mail: webster{at}research.ge.com
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Comparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-L-Glutamate as System Formula-Targeting Radiopharmaceuticals
- Comparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-L-Glutamate as System Formula-Targeting Radiopharmaceuticals
- Latest Advances in Imaging Oxidative Stress in Cancer
- Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer
- The Characterization of 18F-hGTS13 for Molecular Imaging of xC- Transporter Activity with PET
- Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
- Assessment of Tumor Redox Status through (S)-4-(3-[18F]fluoropropyl)-L-Glutamic Acid PET Imaging of System xc- Activity
- 18F-5-Fluoroaminosuberic Acid as a Potential Tracer to Gauge Oxidative Stress in Breast Cancer Models
- A Continuously Infused Microfluidic Radioassay System for the Characterization of Cellular Pharmacokinetics